XYMOGEN Recognized for Fourth Time as an Inc. 5000 Honoree

(firmenpresse) - ORLANDO, FL -- (Marketwire) -- 09/19/11 --

"It is our culture and our team that make XYMOGEN successful," said CEO Brian Blackburn. "This ranking not only serves as recognition of our continued growth, but as a testament to the people, philosophy, and culture that continue to make this journey we call XYMOGEN so exciting."

Blackburn attributes XYMOGEN's growth to a quarterly product pipeline, continuing education events, new marketing initiatives, a customer recognition program, and international expansion. In summer 2011, XYMOGEN broke ground on its new, 136,000 sq. ft. manufacturing facility in Orlando, FL. Blackburn adds, "We are proud to be providing jobs for our in-house staff of 80. We look forward to creating over 50 new jobs over the next two years in the central Florida area." Blackburn notes that the new jobs at XYMOGEN will place the company in a prime position to develop future opportunities.



XYMOGEN has over a quarter century of experience in providing quality professional supplements to healthcare practitioners. As an independent health sciences company, XYMOGEN has introduced numerous innovations to the Functional Medicine community. XYMOGEN's place as the fastest-growing company and brand in the practitioner-channel was reinforced in 2007, 2008, 2010, and 2011 when it was recognized by Inc. Magazine as one of the Inc. 500/5000 fastest growing, private companies in America.

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 19.09.2011 - 14:26 Uhr
Sprache: Deutsch
News-ID 67180
Anzahl Zeichen: 0

contact information:
Town:

ORLANDO, FL

Kategorie:

Hospitals, Facilities and Providers

Diese Pressemitteilung wurde bisher 540 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"XYMOGEN Recognized for Fourth Time as an Inc. 5000 Honoree"
steht unter der journalistisch-redaktionellen Verantwortung von

XYMOGEN (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

XYMOGEN Announces 2012 Schedule for Its Vanguard Neurology Conference Featuring ...

ORLANDO, FL -- (Marketwire) -- 01/09/12 -- XYMOGEN, one of the nation's leading health science companies, has announced the 2012 schedule for the company's international education series, "Vanguard Neurology: The Next Generation" ...

XYMOGEN Announces $10M Quarterly Milestone Surpassed ...

ORLANDO, FL -- (Marketwire) -- 11/14/11 -- XYMOGEN today released its 2011 third-quarter financial results. Revenues of $10.38 million catapulted XYMOGEN over its $10 million mark for a quarter. This represents a 25% increase over the Q-3 2010 reve ...

Alle Meldungen von XYMOGEN